{
    "xml": "<topic id=\"PHP3384\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/cefotaxime\" basename=\"cefotaxime\" title=\"CEFOTAXIME\">\n<title>CEFOTAXIME</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_146\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/cephalosporins/cefotaxime\">Cefotaxime</xref>\n</p>\n<data name=\"vtmid\">3334000</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_341352686\" title=\"Cephalosporins\">Cephalosporins</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34534\" title=\"CEPHALOSPORINS\" namespace=\"/drug-classes/cephalosporins\">CEPHALOSPORINS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP42535\" outputclass=\"indicationsAndDose\" rev=\"1.38\" parent=\"/drugs/cefotaxime\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Uncomplicated gonorrhoea</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>500&#8239;mg for 1 dose.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Infections due to sensitive Gram-positive and Gram-negative bacteria</p>\n<p outputclass=\"therapeuticIndication\">Surgical prophylaxis</p>\n<p outputclass=\"therapeuticIndication\">Haemophilus epiglottitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;g every 12&#8239;hours.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe susceptible infections due to sensitive Gram-positive and Gram-negative bacteria</p>\n<p outputclass=\"therapeuticIndication\">Meningitis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intramuscular injection or by intravenous injection or by intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>8&#8239;g daily in 4 divided doses, increased if necessary to 12&#8239;g daily in 3&#8211;4 divided doses, intramuscular doses over 1&#8239;g should be divided between more than one site.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Emergency treatment of suspected bacterial meningitis or meningococcal disease, before urgent transfer to hospital, in patients who cannot be given benzylpenicillin (e.g. because of an allergy)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 1 month&#8211;11 years</p>\n<p>50&#8239;mg/kg for 1 dose.</p>\n</li>\n<li outputclass=\"patientGroup child\">\n<p>Child 12&#8211;17 years</p>\n<p>1&#8239;g for 1 dose.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1&#8239;g for 1 dose.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP42499\" outputclass=\"sideEffects\" rev=\"1.12\" parent=\"/drugs/cefotaxime\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"rare\">\n<p outputclass=\"title\">Rare</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arrhythmias (following rapid injection)</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP42523\" outputclass=\"pregnancy\" parent=\"/drugs/cefotaxime\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Not known to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP42584\" outputclass=\"breastFeeding\" parent=\"/drugs/cefotaxime\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in milk in low concentration, but appropriate to use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP42506\" outputclass=\"renalImpairment\" parent=\"/drugs/cefotaxime\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p outputclass=\"specificity\">In adults</p>\n<p>If eGFR less than 5&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initial dose of 1&#8239;g then use half normal dose.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">In children</p>\n<p>Usual initial dose, then use half normal dose if estimated glomerular filtration rate less than 5&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP42597\" outputclass=\"directionsForAdministration\" rev=\"1.24\" parent=\"/drugs/cefotaxime\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>Displacement value may be significant, consult local guidelines.</p>\n<p>For intermittent <i>intravenous infusion</i> dilute in glucose 5% <i>or</i> sodium chloride 0.9%; administer over 20&#8211;60 minutes; incompatible with alkaline solutions.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous infusion</i>, give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%. Suggested volume 40&#8211;100&#8239;mL given over 20&#8211;60 minutes; incompatible with alkaline solutions.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3384-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/cefotaxime\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76190\" title=\"Powder for solution for injection\" namespace=\"/drugs/cefotaxime/powder-for-solution-for-injection\">Powder for solution for injection</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78114\" namespace=\"/treatment-summaries/meningococcal-disease-medical-emergency\" title=\"Meningococcal disease, medical emergency\" count=\"1\" rel=\"backlink\">Meningococcal disease, medical emergency</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78125\" namespace=\"/treatment-summaries/gastro-intestinal-system-infections-bacterial\" title=\"Gastro-intestinal system infections, bacterial\" count=\"2\" rel=\"backlink\">Gastro-intestinal system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78145\" namespace=\"/treatment-summaries/cephalosporins\" title=\"Cephalosporins\" count=\"4\" rel=\"backlink\">Cephalosporins</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78228\" namespace=\"/treatment-summaries/urinary-tract-infections\" title=\"Urinary-tract infections\" count=\"2\" rel=\"backlink\">Urinary-tract infections</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78245\" namespace=\"/treatment-summaries/lyme-disease\" title=\"Lyme disease\" count=\"1\" rel=\"backlink\">Lyme disease</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78484\" namespace=\"/treatment-summaries/musculoskeletal-system-infections-bacterial\" title=\"Musculoskeletal system infections, bacterial\" count=\"1\" rel=\"backlink\">Musculoskeletal system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78491\" namespace=\"/treatment-summaries/blood-infections-bacterial\" title=\"Blood infections, bacterial\" count=\"2\" rel=\"backlink\">Blood infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78553\" namespace=\"/treatment-summaries/central-nervous-system-infections-bacterial\" title=\"Central nervous system infections, bacterial\" count=\"8\" rel=\"backlink\">Central nervous system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78577\" namespace=\"/treatment-summaries/respiratory-system-infections-bacterial\" title=\"Respiratory system infections, bacterial\" count=\"2\" rel=\"backlink\">Respiratory system infections, bacterial</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78592\" namespace=\"/treatment-summaries/cardiovascular-system-infections-bacterial\" title=\"Cardiovascular system infections, bacterial\" count=\"1\" rel=\"backlink\">Cardiovascular system infections, bacterial</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_146\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/cephalosporins/cefotaxime\" title=\"Cefotaxime\" count=\"1\" rel=\"link\">Cefotaxime</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34534\" namespace=\"/drug-classes/cephalosporins\" title=\"CEPHALOSPORINS\" count=\"1\" rel=\"link\">CEPHALOSPORINS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76190\" namespace=\"/drugs/cefotaxime/powder-for-solution-for-injection\" title=\"Powder for solution for injection\" count=\"1\" rel=\"link\">Powder for solution for injection</xref>\n</links>\n</topic>",
    "id": "PHP3384",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/cefotaxime",
    "basename": "cefotaxime",
    "title": "CEFOTAXIME",
    "interactants": [
        {
            "id": "bnf_int_146",
            "label": "Cefotaxime"
        }
    ],
    "vtmid": "3334000",
    "drugClassification": [
        "Cephalosporins"
    ],
    "inheritsFromClass": [
        "CEPHALOSPORINS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Uncomplicated gonorrhoea",
                        "html": "Uncomplicated gonorrhoea"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection"
                    ],
                    "textContent": "By intramuscular injection",
                    "html": "By intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "500 mg for 1 dose.",
                        "html": "<p>500&#8239;mg for 1 dose.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Infections due to sensitive Gram-positive and Gram-negative bacteria",
                        "html": "Infections due to sensitive Gram-positive and Gram-negative bacteria"
                    },
                    {
                        "textContent": "Surgical prophylaxis",
                        "html": "Surgical prophylaxis"
                    },
                    {
                        "textContent": "Haemophilus epiglottitis",
                        "html": "Haemophilus epiglottitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intramuscular injection or by intravenous injection or by intravenous infusion",
                    "html": "By intramuscular injection or by intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "1 g every 12 hours.",
                        "html": "<p>1&#8239;g every 12&#8239;hours.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Severe susceptible infections due to sensitive Gram-positive and Gram-negative bacteria",
                        "html": "Severe susceptible infections due to sensitive Gram-positive and Gram-negative bacteria"
                    },
                    {
                        "textContent": "Meningitis",
                        "html": "Meningitis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intramuscular injection or intravenous injection or intravenous infusion"
                    ],
                    "textContent": "By intramuscular injection or by intravenous injection or by intravenous infusion",
                    "html": "By intramuscular injection or by intravenous injection or by intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "8 g daily in 4 divided doses, increased if necessary to 12 g daily in 3&#8211;4 divided doses, intramuscular doses over 1 g should be divided between more than one site.",
                        "html": "<p>8&#8239;g daily in 4 divided doses, increased if necessary to 12&#8239;g daily in 3&#8211;4 divided doses, intramuscular doses over 1&#8239;g should be divided between more than one site.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Emergency treatment of suspected bacterial meningitis or meningococcal disease, before urgent transfer to hospital, in patients who cannot be given benzylpenicillin (e.g. because of an allergy)",
                        "html": "Emergency treatment of suspected bacterial meningitis or meningococcal disease, before urgent transfer to hospital, in patients who cannot be given benzylpenicillin (e.g. because of an allergy)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection or intramuscular injection"
                    ],
                    "textContent": "By intravenous injection or by intramuscular injection",
                    "html": "By intravenous injection or by intramuscular injection"
                },
                "child": [
                    {
                        "textContent": "50 mg/kg for 1 dose.",
                        "html": "<p>50&#8239;mg/kg for 1 dose.</p>",
                        "ageGroup": "1 month&#8211;11 years"
                    },
                    {
                        "textContent": "1 g for 1 dose.",
                        "html": "<p>1&#8239;g for 1 dose.</p>",
                        "ageGroup": "12&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "1 g for 1 dose.",
                        "html": "<p>1&#8239;g for 1 dose.</p>"
                    }
                ]
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "rare": [
                    {
                        "type": "rare",
                        "textContent": "Arrhythmias (following rapid injection)",
                        "html": "Arrhythmias (following rapid injection)",
                        "frequency": "rare",
                        "specificity": {
                            "textContent": "Rare",
                            "html": "Rare"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Not known to be harmful.",
                "html": "<p>Not known to be harmful.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in milk in low concentration, but appropriate to use.",
                "html": "<p>Present in milk in low concentration, but appropriate to use.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In adults",
                    "html": "In adults",
                    "patientType": "adults"
                },
                "textContent": "If eGFR less than 5 mL/minute/1.73 m2, initial dose of 1 g then use half normal dose.",
                "html": "<p>If eGFR less than 5&#8239;mL/minute/1.73&#8239;m<sup>2</sup>, initial dose of 1&#8239;g then use half normal dose.</p>"
            },
            {
                "type": "doseAdjustments",
                "specificity": {
                    "textContent": "In children",
                    "html": "In children",
                    "patientType": "children"
                },
                "textContent": "Usual initial dose, then use half normal dose if estimated glomerular filtration rate less than 5 mL/minute/1.73 m2.",
                "html": "<p>Usual initial dose, then use half normal dose if estimated glomerular filtration rate less than 5&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Displacement value may be significant, consult local guidelines.\n\nFor intermittent intravenous infusion dilute in glucose 5% or sodium chloride 0.9%; administer over 20&#8211;60 minutes; incompatible with alkaline solutions.",
                "html": "<p>Displacement value may be significant, consult local guidelines.</p><p>For intermittent <i>intravenous infusion</i> dilute in glucose 5% <i>or</i> sodium chloride 0.9%; administer over 20&#8211;60 minutes; incompatible with alkaline solutions.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion, give intermittently in Glucose 5% or Sodium chloride 0.9%. Suggested volume 40&#8211;100 mL given over 20&#8211;60 minutes; incompatible with alkaline solutions.",
                "html": "<p>For <i>intravenous infusion</i>, give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%. Suggested volume 40&#8211;100&#8239;mL given over 20&#8211;60 minutes; incompatible with alkaline solutions.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76190",
                "label": "Powder for solution for injection",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78114",
                "label": "Meningococcal disease, medical emergency",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78125",
                "label": "Gastro-intestinal system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78145",
                "label": "Cephalosporins",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78228",
                "label": "Urinary-tract infections",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78245",
                "label": "Lyme disease",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78484",
                "label": "Musculoskeletal system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78491",
                "label": "Blood infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78553",
                "label": "Central nervous system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78577",
                "label": "Respiratory system infections, bacterial",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78592",
                "label": "Cardiovascular system infections, bacterial",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_146",
                "label": "Cefotaxime",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34534",
                "label": "CEPHALOSPORINS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76190",
                "label": "Powder for solution for injection",
                "type": "medicinalForm"
            }
        ]
    }
}